Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Peptide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel fragment condensation method for salmon calcitonin acetate ensures high purity and yield for pharmaceutical supply chains.
Patent CN108059666A reveals solid-liquid combination for Semaglutide. Reduces synthesis steps, improves purity, and offers cost reduction in API manufacturing for global supply chains.
Advanced soluble fragment strategy for Palmitoyl tetrapeptide-7 production. Overcomes purification bottlenecks and ensures high-purity supply for cosmetic manufacturing.
Patent CN111479800B reveals solid-phase synthesis for kappa opioid agonists. Offers high purity and scalable production for reliable pharmaceutical intermediate supply chains.
Novel preparation method for Somalutide side chain intermediates using orthogonal protection. Enhances purity and scalability for peptide manufacturing.
Patent CN110240551B reveals a high-yield catalytic route for Fmoc-beta-Ala-Gly-OH, offering superior purity and cost efficiency for peptide manufacturing.
Patent CN113135991A reveals a fragment condensation method reducing D-His impurities. Enhances purity and yield for scalable GLP-1 manufacturing.
Novel full liquid-phase method for Alarelin synthesis achieves over 95 percent crude purity. Offers significant cost reduction and scalability for pharmaceutical intermediates manufacturing.
Patent CN103387601B details novel heterocyclic peptide synthesis for antiviral drugs. Discover cost-effective manufacturing and reliable supply chain solutions for serine protease inhibitors.
Novel thalidomide-based PROTACs for fibrosis and cancer. Efficient solid-phase synthesis ensures high purity and scalable supply chain solutions.
Patent CN101838308A reveals a streamlined solid-phase route for Eptifibatide using single-protected amino acids and rapid hydrogen peroxide oxidation, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Novel solid-phase method enhances purity and yield. Reliable supply chain for complex peptide intermediates with optimized cyclization.
Patent CN104326960A details aqueous synthesis improving purity and yield. Offers supply chain reliability and cost reduction for peptide manufacturing partners globally.
Advanced solid-phase method improves purity and yield for bremelanotide manufacturing, offering cost reduction and supply chain stability for global partners.
Advanced Fmoc solid-phase synthesis for Triptorelin bulk drug. Patent CN103012565A offers high yield, low racemization, and scalable manufacturing for reliable supply chains.
Patent CN113698458A details a full liquid-phase method for triptorelin, offering high purity crude product and significant cost reduction in peptide manufacturing compared to solid-phase routes.
Patent CN102190709A details a novel two-fragment solid-phase synthesis for LH-RH derivatives, offering high purity and cost-effective manufacturing solutions.
Patent CN120659800A details high-purity tetrapeptide synthesis reducing D-isomer impurities for scalable API manufacturing and cost-effective supply chains.
Novel solid-liquid combination method for Exenatide reduces purification difficulty and enhances supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN103087177A details microwave-assisted solid-phase synthesis of stable GLP-1 analogues with extended half-life, offering cost-effective manufacturing solutions.